A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines()

BACKGROUND: To contribute to the global demand for oral cholera vaccine (OCV), the production of Euvichol® was scaled up with elimination of thimerosal. To demonstrate the equivalence of the variations, a study was carried out in the Philippines. METHODS: Healthy male and female adults and children...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Paola, Ligsay, Antonio D., Olveda, Remigio, Choi, Seuk Keun, Kim, Deok Ryun, Park, Ju Yeon, Park, Ju Yeong, Syed, Khalid Ali, Dey, Ayan, Kim, Yang Hee, Lee, Sung Hee, Kim, Jayoung, Chon, Yun, Digilio, Laura, Kim, Chan Wha, Excler, Jean-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026293/
https://www.ncbi.nlm.nih.gov/pubmed/29895500
http://dx.doi.org/10.1016/j.vaccine.2018.05.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026293/
https://www.ncbi.nlm.nih.gov/pubmed/29895500
http://dx.doi.org/10.1016/j.vaccine.2018.05.102

Ejemplares similares